KD026

· Response Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KD026, covering 2023-11-18 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus [Phase 2]